A multi-country outbreak of Salmonella Stanley ST2045 infections has been linked to the consumption of flavoured noodle products, according to a joint rapid outbreak assessment published by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) on 1 July 2026. The assessment identifies the specific food vehicle as flavoured noodle products, though the exact source within the supply chain remains under investigation. The outbreak has affected multiple EU member states, with cases reported in recent weeks, prompting the agencies to issue the assessment to coordinate tracing and control measures.
The document, approved on the same day, is classified as a rapid outbreak assessment, a tool used by EFSA and ECDC to provide timely scientific advice during foodborne outbreaks. It falls under the biological hazards and monitoring of foodborne diseases topics, reflecting the agencies' mandate to protect public health through food safety. The assessment does not specify the number of cases or countries involved in detail, but it calls for enhanced surveillance and traceability of flavoured noodle products. The outbreak strain, Salmonella Stanley ST2045, is a known pathogen that can cause severe gastrointestinal illness, particularly in vulnerable populations.
The assessment impacts several stakeholders. EU consumers face a direct health risk, particularly those who consume flavoured noodle products, and may need to check product recalls or avoid certain brands. Producers and distributors of flavoured noodle products are affected as they may face supply chain disruptions, product recalls, and reputational damage, with potential financial losses from withdrawn batches. National food safety authorities in EU member states are impacted as they must implement traceability measures, coordinate with the European Commission's Rapid Alert System for Food and Feed (RASFF), and communicate public health warnings. EFSA and ECDC themselves are involved in coordinating the response and updating risk assessments as new data emerges.
No prior coverage of this outbreak exists in the last 180 days. The assessment does not specify a timeline for follow-up, but similar rapid outbreak assessments typically lead to further investigations by national authorities and potential updates as more cases or traceability information becomes available.